phenylalanine has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galba, J; Kovac, A; Michalicova, A; Novak, M; Parrak, V | 1 |
| Albasanz, JL; Barrachina, M; Ferrer, I; MartÃn, M; Perez-Buira, S; Rodriguez, A | 1 |
2 other study(ies) available for phenylalanine and Tauopathies
| Article | Year |
|---|---|
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Humans; Kynurenine; Phenylalanine; Rats; Rats, Inbred SHR; Rats, Transgenic; Tandem Mass Spectrometry; Tauopathies; Tryptophan; Tyrosine | 2016 |
Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease.
Topics: Adenosine A1 Receptor Agonists; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aged; Aged, 80 and over; Cadaver; Cognition Disorders; Colforsin; Dementia; Female; Frontal Lobe; Hippocampus; Humans; Male; Middle Aged; Phenylalanine; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Silver Staining; Tauopathies | 2007 |